US Stock MarketDetailed Quotes

AVTX Avalo Therapeutics

Watchlist
  • 12.4000
  • -0.3781-2.96%
Trading Jul 22 09:30 ET
12.82MMarket Cap-243P/E (TTM)

Avalo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Avalo Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

-100.00%
EPS(YoY)

-141.00

+30.88%
Analyst Rating

Buy

Jun 30, 2024

Avalo Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q4571.000K / 300.000K--
--2023/Q3236.000K / 1.000M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q4571.000K / 300.000K--
--2023/Q3236.000K / 1.000M--

Unlock Free Earnings Estimates

Avalo Therapeutics Earnings Reports

  • Avalo Therapeutics | 10-Q/A: Quarterly report (Amendment)

    Jul 11 16:20 ET

  • Avalo Therapeutics | 10-Q: Quarterly report

    May 13 07:34 ET

  • Avalo Therapeutics | 10-K: Annual report

    Mar 29 16:08 ET

  • Avalo Therapeutics: Q3 2023 Earnings Report

    Nov 9, 2023 07:21 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg